SEC Form 4 · accession 0001929980-26-000382
Southern Cross Acquisition I Corp. · NCO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Period of report
Jul 22, 2026
Accepted (ET)
Jul 24, 2026 · 5:36 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0002116230
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF2,F1 | Jul 22, 2026 | P$0 | 15,000 | — | A | 3,100,300 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Private WarrantsF1,F2,F4,F3 | $11.50 | Jul 22, 2026 | P | 15,000 | A | — | — | Ordinary Shares | 15,000 | 239,300 | D |
| Private RightsF2,F1,F6,F5 | $0.00 | Jul 22, 2026 | P | 15,000 | A | — | — | Ordinary Shares | 3,750 | 239,300 | D |
Explanation of responses
- F1Southern Cross Acquisition I Sponsor Corp., a Cayman Islands exempted company (the "Sponsor"), is the record holder of the securities reported herein. Mr. Dong Chen is the sole member and director of the Sponsor, which entitles him to voting, dispositive or investment power over the Sponsor. As such, Mr. Dong Chen is deemed to have voting and dispositive rights over the securities of Southern Cross Acquisition I Corp. (the "Issuer") held by the Sponsor.
- F2Represents 15,000 ordinary shares included in 15,000 additional private units (the "Private Units") purchased by the Sponsor in a private placement (the "Private Placement") simultaneously with the closing of the Issuer's initial public offering in connection with the underwriter's exercise of their over-allotment option, at a purchase price of $10 per Private Unit. Each Private Unit consists of one ordinary share, one redeemable warrant, and one right to receive one-fourth (1/4) of one ordinary share.
- F3Represents 15,000 ordinary shares issuable upon exercise of 15,000 private warrants of the Issuer underlying the Private Units acquired by the Sponsor in the Private Placement. Each private warrant entitles the holder to purchase one ordinary share at an exercise price of $11.50 per share.
- F4As described in the Warrant Agreement dated July 20, 2026, between the Issuer and Continental Stock Transfer & Trust Company, which is filed as Exhibit 4.4 to the Issuer's Registration Statement on Form S-1 (File No. 333-296723)(the "Registration Statement"), the private warrants will become exercisable on the later of (i) 30 days after the completion of an initial business combination and (ii) one year from the date that the Registration Statement is declared effective, and will expire five years after the completion of the Issuer's initial business combination or earlier upon redemption or liquidation, as described in the Registration Statement.
- F5Represents 3,750 ordinary shares issuable upon conversion of 15,000 private rights of the Issuer, each private right entitling the holder to receive one-fourth (1/4) of one ordinary share of the Issuer, underlying the Private Units acquired by the Sponsor in the Private Placement.
- F6As described in the Rights Agreement dated July 20, 2026, between the Issuer and Continental Stock Transfer & Trust Company, which is filed as Exhibit 4.6 of the Registration Statement, each private right of the Issuer will automatically convert into one-fourth (1/4) of one ordinary share of the Issuer upon the completion of the Issuer's initial business combination.